MedPath

BAYER (SOUTH EAST ASIA) PTE LTD

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

76

HSA:73
NMPA:3

Drug Approvals

Ethinylestradiol and Cyproterone Acetate Tablets

Product Name
达英-35
Approval Number
国药准字HJ20170210
Approval Date
Jan 4, 2023
NMPA

Ethinylestradiol and Cyproterone Acetate Tablets

Product Name
达英-35
Approval Number
国药准字HJ20170209
Approval Date
Jan 4, 2023
NMPA

Ethinylestradiol and Cyproterone Acetate Tablets

Product Name
达英-35
Approval Number
国药准字J20140114
Approval Date
Oct 22, 2018
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.